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Neuronal injury in bacterial meningitis is caused by the interplay of host inflammatory responses and
direct bacterial toxicity. We investigated the mechanisms by which pneumolysin, a cytosolic pneumococ-
cal protein, induces damage to neurons. The toxicity after exposure of human SH-SY5Y neuroblastoma
cells and hippocampal organotypic cultures to pneumolysin was time- and dose-dependent. Pneumolysin
led to a strong calcium influx apparently mediated by pores on the cell membrane formed by the toxin
itself and not by voltage-gated calcium channels. Buffering of intracellular calcium with BAPTA-AM [1,
2-bis (o-aminophenoxy) ethane N, N, N, N-tetraacetic acid tetra(acetomethoxyl) ester] improved survival
of neuronal cells following challenge with pneumolysin. Western blotting revealed increased phosphory-
lation of p38 mitogen-activated protein kinase (p38 MAPK) as early as 30 min after challenge with
pneumolysin. SB 203580, a potent and selective inhibitor of p38 MAPK, rescued human neuronal cells from
pneumolysin-induced death. Inhibition of the mitochondrial permeability transition pore using bongkrek-
ate and caspase inhibition also improved survival following challenge with the toxin. Modulation of cell
death pathways activated by pneumolysin may influence the outcome of pneumococcal meningitis.
© 2003 Elsevier Science (USA)INTRODUCTION
Despite introduction of effective antibacterial ther-
apy more than 50 years ago, neurologic sequelae and
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All rights reserved. 355mortality from pneumococcal meningitis, the most
frequent form of bacterial meningitis in adults, remain
high (Quagliarello & Scheld, 1992; Schuchat et al.,
1997). Data from animal models of meningitis and
postmortem studies of human brains point to neu-
ronal cell death in the hippocampal formation as the
pathologic substrate of neuropsychologic deficits
among survivors of bacterial meningitis (Zysk et al.,
1996; Nau et al., 1999; Wellmer et al., 2000; Nau &
Bru¨ck, 2002) Several lines of evidence suggest thatKey Words: pneumolysin; p38 mitogen-activa otein kinase; calcium; meningitis; apoptosis.ted prbacteria may directly damage neurons (Braun et al.,E-mail: mau@gwdg.de.
2002) or trigger an inflammatory burst involving the
generation of toxic compounds by neutrophils and
glial cells ultimately leading to neuronal cell death
(Kim et al., 1995; Kim & Ta¨uber, 1996; van Furth
et al., 1996). A detailed account of how bacteria
might directly inflict damage to neurons is hitherto
lacking.
Pneumolysin is a major virulence factor of pneu-
mococci and belongs to a large family of highly
homologous bacterial toxins (Rossjohn et al., 1998;
Rubins & Janoff, 1998). It causes injury to pulmo-
nary alveolar epithelial cells (Rubins et al., 1993) and
appears to be the causative factor of hearing loss
and cochlear damage during experimental meningi-
tis (Winter et al., 1997). The effects of pneumolysin
are mediated by two mechanisms: binding to mem-
branes leading to damage through pore formation,
and activation of the complement system in a non-
immunospecific manner through direct interaction
with the IgG domain Fc (Mitchell et al., 1991; Ross-
john et al., 1998).
The mitogen-activated protein kinase (MAPK) su-
perfamily plays a critical role in signal transduction
from the cell surface to the nucleus and becomes ac-
tivated by a variety of stimuli ranging from growth
factors to cytokines and cellular stress (Martin-Blanco,
2000; Ono & Han, 2000). Depending on cellular con-
text, the p38 MAPK appears to participate in both
inflammatory responses and cell death (Harper &
LoGrasso, 2001; Junn & Muradian, 2001; Maher, 2001;
McLaughlin et al., 2001; Mota et al., 2001). Apparently
p38 MAPK is central to both excitotoxic and nitric
oxide-induced neuronal apoptosis (Kawasaki et al.,
1997; Ghatan et al., 2000).
The purpose of this work was to determine whether
pneumococci have a directly toxic effect on neuronal
cells and to define the mechanisms involved. We have
previously shown that apoptosis of neurons occurs in
the dentate gyrus of the hippocampal formation in
animals and humans with meningitis (Zysk et al., 1996;
Nau et al., 1999). In this study we assessed the impact
of pneumolysin, a pore forming bacterial toxin, on
SH-SY5Y human neuronal cells and hippocampal or-
ganotypic cultures. To determine the signaling events
following challenge with pneumolysin on neuronal
cells, we assessed intracellular calcium [Ca2]i levels
and activation of p38 MAPK. The specific inhibitor SB
203580 prevented cell death, indicating that activation




RPMI-1640 medium, fetal calf serum (FCS), and an-
tibiotics were all from Biochrom, Berlin, Germany.
Bongkrekate, N-acetylcysteine, thapsigargin, ionomy-
cin, and Hoechst 33258 were purchased from Sigma,
Deisenhofen, Germany. SB203580, N-benzyloxycar-
bonyl-Val–Ala–Asp-fluoromethyl-ketone (z-VAD-fmk),
BAPTA-AM [1,2-bis(o-aminophenoxy) ethane-N,N,N,
N-tetraacetic acid tetra(acetomethoxyl)ester] and rab-
bit antibodies to the phosphorylated and nonphos-
phorylated human p38 MAPK were from Calbiochem,
San Diego, California, USA. Horseradish peroxidase-
conjugated goat anti-rabbit antibodies were from
Dako, Denmark. Enhanced chemiluminescence (ECL-
Plus) reagents were obtained from Amersham Phar-
macia Biotech, UK, and fura-2 AM from Molecular
Probes, Eugene, Oregon, USA, carbonyl cyanide p-
(trifluoromethoxy) phenylhydrazone (FCCP) and cad-
mium chloride (CdCl2) from Sigma, Deisenhofen, Ger-
many. The glutamate receptor antagonists (RS)-3-(2-
carboxypiperazin-4-yl)-propyl-1-phosphonic acid
(CPP) and 6-cyano-7-nitroquinoxaline-2,3-dione diso-
dium (CNQX) were from Tocris (Tocris Cookson Ltd,
Bristol, UK). All materials for in situ tailing were from
Roche Molecular Biochemicals, Mannheim, Germany.
Organotypic Hippocampal Cultures
NMRI mice were bred at the animal care facility of
the Max Planck Institute for Biophysical Chemistry,
Goettingen, Germany. Five- to seven-day-old NMRI
mice were decapitated and the hippocampal forma-
tions prepared and cut transversally with a McIlwain
tissue chopper into slices 400 m thick under sterile
conditions (Ga¨hwiller, 1981; von Mering et al., 2001).
Slices were kept in Grey’s balanced salt solution
(GBSS) supplemented with 36 mM d-glucose at 4°C
for 30 min. Thereafter, slices were embedded in
plasma clots on glass coverslips, which were then
coagulated by the addition of thrombin. Coverslips
were transferred to plastic culture tubes containing
culture medium composed of 50% Eagle’s basal me-
dium, 25% Hanks’ balanced salt solution, 25% heat-
inactivated horse serum supplemented with glu-
tamine (1 mM), and d-glucose (36 mM). Culture tubes
were placed in a roller device rotating at 10 revolu-
tions/h in an air-ventilated incubator at 36°C. The
medium was changed twice. After 7 days, cultures
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challenged with pneumolysin (0.6 or 6 g/ml) for 48 h
were compared with those treated with medium only.
Cell Culture
SH-SY5Y human neuroblastoma cells were a gener-
ous gift from Dr. D. Isbrandt, Zentrum fu¨r Molekulare
Neurobiologie, University of Hamburg, Germany, and
were routinely maintained in RPMI-1640 supple-
mented with 10% FCS, penicillin (100 IU/ml), and
streptomycin (100 g/ml) at 37°C in a humidified
atmosphere of 95% air and 5% CO2.
Measurement of Cell Viability
Cell viability was determined by colorimetric
monitoring of the conversion of 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to
formazan. SH-SY5Y cells were seeded into 96-well
plates at a density of 105/cm2. After stimulation with
heat-inactivated bacteria or pneumolysin, culture me-
dium was removed from the wells and cells were
incubated for 30 min at 37°C followed by cell lysis and
absorption measurement at 570 nm with a Dynatech
spectrophotometer (Dynatech, Denkendorf, Ger-
many). The validity of the MTT reduction assay was
confirmed by comparison to results obtained from
trypan blue exclusion assay. Both assays resulted in
equal percentages of surviving cells after treatment
with various toxic agents.
Propidium Iodide staining of OTCs Organotypic
Hippocampal Cultures
The vital dye propidium iodide (PI) was used to
determine cell membrane integrity in organotypic hip-
pocampal cultures (OTCs). After treatment with pneu-
molysin for 48 h, medium was replaced by PI (25
g/ml dissolved in medium) followed by incubation
for 3 h at 36°C. Cultures were then photographed with
an Axiophot fluorescence microscope (Zeiss,
Oberkochen, Germany). Following fixation with for-
malin, cultures were again stained with PI and the
pre- versus postfixation PI fluorescence ratio was cal-
culated.
Chromatin Staining
SH-SY5Y cells were grown on coverslips at a den-
sity of 105/cm2. After stimulation with various pneu-
molysin concentrations, cells were fixed with 4% para-
formaldehyde (dissolved in PBS) for 30 min, perme-
abilized with methanol, and then rinsed three times
with PBS and incubated with 120 ng/ml Hoechst
33258 dye for 30 min. Stained chromatin was visual-
ized using a Leica fluorescence microscope equipped
with UV illumination.
In Situ Tailing
In situ tailing (IST) was performed as described
(Stringaris et al., 1997) except that pretreatment with
proteinase K was omitted. Coverslips were permeabil-
ized with methanol and then incubated with tailing
mixture containing terminal transferase and digoxige-
nin-labeled nucleotides for 1 h at 37°C according to the
instructions of the manufacturer. After being blocked
with fetal calf serum, cells were incubated with
anti-digoxigenin antibody for 1 h. The reaction was
visualized using 4-nitrobluetetrazolium/5-bromo-4-
chloro-3-indolyl phosphate (NBT/BCIP). Counter-
staining was performed with nuclear fast red alumi-
num hydroxide and results were visualized on a con-
ventional Olympus microscope.
Preparation of Pneumolysin
Pneumolysin was purified as described (Paton et al.,
1993). Recombinant toxin was overexpressed in Esch-
erichia coli strain JM109. Bacteria were lysed by soni-
cation, and pneumolysin was purified by hydrophobic
and ion-exchange chromatography. Toxin purity was
assessed by SDS–polyacrylamide gel electrophoresis
followed by Coomassie blue staining which showed a
single 52-kDa band accounting for 95% of the protein.
Western Blot Analysis
Proteins were extracted as previously described
(Tieu et al., 1999) with minor modifications: Cells were
grown at a density of 106/cm2 in six-well plates and
treated with pneumolysin (0.5 g/ml) or medium.
Following stimulation, cells were removed from the
plates and washed three times with PBS. Cell pellets
were immediately frozen in liquid nitrogen and stored
at80°C until protein extraction. Cellular protein was
obtained by incubation for 20 min in lysis buffer [10
mM Tris buffer (pH 7.4) containing 0.15 mM NaCI, 5
mM EDTA, 1% (v/v) Triton X-100, and protease in-
hibitor cocktail tablets (Roche, Mannheim, Germany)]
and then centrifuged at 20,800g for 30 min at 4°C.
Alternatively, a rapid protein extraction protocol in-
volving sonication of cell samples was used instead of
ice-cold lysis. Cells were collected in lysis buffer con-
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taining 50 mM -glycerol phosphate and sonified in a
Branson sonifier.
The protein-containing supernatants were diluted
1:1 in sample buffer [0.16 M N,N-bis(2-hydroxy-
ethyl)glycine (Bicine), 0.36 M bis(2-hydroxyethyl)-
imino-tris(hydroxymethyl)methane (Bis–Tris), 15%
(w/v) sucrose, 1% (w/v) SDS, 0.05% (w/v), bromphe-
nol blue] and heated for 5 min at 95°C. Electrophoresis
was performed with 10% T/5% C gels (Wiltfang et al.,
1991; Smirnov et al., 2000). Following electroblotting
for 90 min, polyvinyl difluoride (PVDF) membranes
were heated for 3 min at 95°C and blocked for 2 h at
room temperature (RT) in PBS containing 0.1% (v/v)
Tween (PBST) with 5% (w/v) nonfat dry milk. Mem-
branes were then incubated overnight at 4°C with
primary antibody diluted 1:1000 in PBST. The next
day, following washes, membranes were incubated
for 1 h at RT with secondary antibody diluted 1:2000
in PBST. Membranes were washed, subsequently
placed in 4 ml of ECL-Plus chemiluminescent sub-
strate, and then exposed to Konica X-Ray Medical
Films (Konica Corp. Tokyo, Japan).
Assessment of Pneumolysin Concentrations
Pneumolysin was detected as a band at 53 kDa and
densitometrically quantitated using the software NIH
Image 1.62. Recombinant pneumolysin was taken as a
standard.
Measurement of Intracellular Calcium Levels
Changes in intracellular calcium ([Ca2]i) were mea-
sured in SH-SY5H cells attached to glass coverslips
after 2–5 days in culture. Cell layers were incubated
with RPMI-1640 containing 10 M fura-2 AM at 37°C
for 30 min. The RPMI-1640 medium used contains
0.846 mM Ca2 (supplier’s data). Cells were rinsed
with RPMI or the appropriate bathing solutions and
further incubated for 30 min at 37°C to allow complete
deesterification.
Changes in [Ca2]i were measured using a CCD
camera system (TILL Photonics, Martinsried, Ger-
many) (Ladewig & Keller, 2000). A computer-con-
trolled monochromator (Polychrome II, TILL Photon-
ics) was connected to an Axioscope microscope (Zeiss,
Go¨ttingen, Germany) via quartz fiberoptics and a min-
imum number of optical components for maximum
fluorescence excitation (objective Achroplan W 63x,
0.9W). The CCD camera displayed 12-bit dynamics
and an A/D converter with 12.5-MHz sampling rate.
Calcium changes in defined regions of interest (ROIs)
were monitored online using the TILL Vision Software
V3.3 (TILL Photonics, Martinsried, Germany). Back-
ground fluorescence was subtracted from the re-
corded values. The measured fluorescence ratio [R] at
wavelengths 360 and 390 nm was used to calculate
[Ca2]i using the equation of Grynkiewicz et al. (1985).
The Kd of fura-2 was experimentally determined as
224 nM (Tsien et al., 1982; Ladewig & Keller, 2000).
Rmin and Rmax were determined by exposing the cells to
25 M ionomycin in the presence of either 0 mM Ca2
and 10 mM EGTA or 10 mM Ca2.
Further analysis was performed off-line with the
IGOR software (Wavemetrics, Lake Oswego, OR,
USA). Bathing solutions were either RPMI-1640 or (in
mM) NaCl 140, KCl 2, CaCl2 2.5, MgCl2 1, Hepes 10,
glucose 40, and bovine serum albumin 0.05% at pH
7.3. For nominally Ca2-free solutions MgCl2 was sub-
stituted for CaCl2 without adding EGTA (Crudt et al.,
1996).
Animal Model of Experimental Pneumococcal
Meningitis
New Zealand white rabbits were kept at the Tierex-
perimentelle Einrichtung of the University of Go¨ttin-
gen. All measures were taken to reduce animal suffer-
ing to a minimum, and experiments were approved by
the animal care committee of the University of Go¨ttin-
gen. Experimental pneumococcal meningitis was in-
duced in rabbits as previously described (Zysk et al.,
1996). In brief, a Streptococcus pneumoniae type 3 strain
originally isolated from an adult with meningitis was
used. After several passages in rabbits, infected cere-
brospinal fluid was cultured on blood agar plates and
bacteria were suspended in sterile saline solution. An-
esthesia was induced by intramuscular injections of
ketamine (25 mg/kg) and xylazine (5 mg/kg) and
maintained with intravenous urethane for the entire
duration of the experiment (24 h). Animals were inoc-
ulated intracisternally with 106 colony-forming units
(CFU) of S. pneumoniae. Cerebrospinal fluid was with-
drawn 24 h later and immediately stored at 20°C.
Animals were sacrificed using 75 mg intravenous thio-
pental.
Statistics
Groups were compared by two-tailed parametric
one-way ANOVA. P values were adjusted for re-
peated testing by Bonferroni‘s posttest correction. A
value of P  0.05 was considered statistically signifi-
cant.
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RESULTS
Purified Pneumolysin-Induced Cell Death in SH-
SY5Y Human Neuroblastoma Cells and OTCs
In preliminary experiments, application of heat-in-
activated bacteria did not result in significant toxicity
to neuronal SH-SY5Y cells.
Purified pneumolysin (0.5–3 g/ml) was added to
culture medium for up to 24 h. Neurotoxicity of pneu-
molysin occurred in a dose- and time-dependent fash-
ion (Fig. 1A); following 3 h of stimulation with 0.5
g/ml pneumolysin almost 40% of cells were dead.
Chromatin staining of SH-SY5Y cells with pneumoly-
sin revealed cells exhibiting chromatin condensation
and fragmentation (Fig. 1B). Pneumolysin led to DNA
fragmentation of human neuronal cells as exhibited by
in situ tailing (Fig. 1C).
The effects of pneumolysin in a tissue context were
investigated in hippocampal OTCs. Pneumolysin at a
dose of 0.6 g/ml induced cell death largely restricted
to the dentate gyrus of the hippocampal formation
(Fig. 1D).
Pneumolysin Led to Perturbations of Ca2
Homeostasis in Human Neuroblastoma Cells
The minimum pneumolysin dose capable of leading
to measurable cell death over a short period (0.5 g/
ml) was used. SH-SY5Y human neuroblastoma cells
were loaded with fura-2 AM and subsequently ob-
served by CCD-camera imaging. Then, stimulation
began with 0.5 g/ml pneumolysin. Addition of
RPMI medium to cells had no effect on intracellular
Ca2 concentrations (Fig. 2A). Approximately 10 min
after addition of pneumolysin, nearly half of the re-
corded cells exhibited sudden rises of [Ca2]i lasting
30 sec to 4 min. These were followed by a rapid
decrease in [Ca2]i (Fig. 2B). [Ca
2]i initially returned
to prestimulation levels, yet after subsequent peaks,
[Ca2]i remained persistently elevated (Fig. 2B). Oscil-
lations of intracellular calcium occurred repeatedly at
high [Ca2]i without reaching basal Ca
2 levels over a
period of 60 min.
Calcium Oscillations Were due to Influx of
Extracellular Ca2
Cells loaded with fura-2 AM were exposed to Ca2-
free bathing solution before the addition of 0.5 g/ml
pneumolysin. No alterations in [Ca2]i were observed
(Fig. 3A). Conversely, when the bathing solution con-
tained high concentrations (2 mM) of extracellular
Ca2, high-pitched oscillations of [Ca2]i were ob-
served after pneumolysin challenge, but not after ad-
dition of medium only. The pneumolysin-induced am-
plitudes of Ca2 oscillations in the presence of high
extracellular Ca2 concentrations by far exceeded
those observed in RPMI culture medium.
To assess the contribution of intracellular Ca2
stores to pneumolysin-induced calcium oscillations
thapsigargin was used. Preincubation with 100 nM
thapsigargin led to a transient increase in [Ca2]i
which lasted approximately 10 min. Thapsigargin did
not abolish pneumolysin-induced Ca2 oscillations
(Fig. 3B). Addition of the protonophore FCCP, an un-
coupler of the mitochondrial respiration, also did not
inhibit pneumolysin-induced cytoplasmic calcium el-
evations (Fig. 3C).
To determine if Ca2 influx resulted from opening of
voltage-dependent Ca2 channels, cells were loaded
with 200 M CdCl2. Blocking of calcium channels with
cadmium did not abolish pneumolysin-induced eleva-
tions of [Ca2]i (Fig. 4A). Furthermore, selective block-
ing of NMDA and AMPA/kainate receptors with 10
M CPP and 5 M CNOX, respectively, did not in-
hibit pneumolysin-induced elevations of intracellular
calcium (Fig. 4B). Cells were also depolarized by add-
ing KCl to a final concentration of 60 mM. The mag-
nitudes of KCl (60 mM)-evoked Ca2 currents were
lower than those observed after addition of pneumo-
lysin by one order of magnitude (data not shown).
Furthermore, when KCl (60 mM) was added to me-
dium during pneumolysin stimulation, a further in-
crease in Ca2 amplitudes was observed. These results
strongly suggest that the pneumolysin pore itself and
not voltage-gated Ca2 channels is responsible for
Ca2 influx after pneumolysin stimulation.
Chelation of Intracellular Calcium with BAPTA-
AM Reduced Neuronal Pneumolysin-Induced
Cell Death
Cells were preincubated with 10 M BAPTA-AM
prior to challenge with 0.5 g/ml pneumolysin or
medium. BAPTA-AM pretreatment strongly en-
hanced survival of cells challenged with pneumolysin
(Fig. 5). However, BAPTA-AM exerted toxic effects on
SH-SY5Y cells as compared with medium-treated con-
trols. Also, although buffering of intracellular calcium
resulted in survival improvement of human neuronal
cells as assessed by the MTT test it did not completely
abolish morphologic alterations occuring after treat-
ment with pneumolysin.
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FIG. 1. Neuronal injury caused by pneumolysin. (A) Pneumolysin led to time-dependent toxicity on SH-SY5Y human neuronal cells as
determined by the MTT test. Pneumolysin was added for the periods indicated at a final concentration of 0.5 g/ml to cell culture medium.
Data are expressed as means SD. ***P 0.001; for each condition n 8. (B) SH-SY5Y human neuronal cells undergoing pneumolysin-induced
cell death showing morphologic features of apoptosis. After exposure to medium only (bottom) or 0.5 g/ml (top) for 6 h, cells were stained
with the fluorescent chromatin dye Hoechst 33258. Pneumolysin-challenged as opposed to medium-treated cells displayed chromatin
condensation and nuclear fragmentation. (C) In situ tailing (IST) of human neuronal cells. Cells were treated with either 0.5 g/ml pneumolysin
or medium for 6 h. Top: Cells with condensed nuclei were stained with IST after stimulation with pneumolysin (arrow points to a
representative cell). Bottom: Medium-treated neuronal cells were IST negative. (D) Propidium iodide staining of hippocampal OTCs. Top:
Propidium iodide uptake in the dentate gyrus of cultures challenged for 48 h with 0.6 g/ml pneumolysin. Bottom: OTC treated with medium
only showed virtually no dye uptake.
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Activation p38 MAPK Was Important in
Pneumolysin Induced Cell Death
Western blotting experiments using a phospho-spe-
cific p38 MAPK antibody revealed p38 MAPK phos-
phorylation as early as 30 min after stimulation, with
pneumolysin increasing steadily thereafter (Fig. 6B).
Cells were incubated with the selective inhibitor of
p38 MAPK, SB 203580, in the presence of pneumoly-
sin. Near-complete suppression of cell death was
achieved when cells were examined 3 h following
stimulation with pneumolysin. When the effects of
p38 MAPK inhibition were assessed 12 h following
co-incubation of SB 203580 and pneumolysin, approx-
imately 60% of cells were still alive compared with less
than 10% of those treated with pneumolysin only (Fig.
6A).
Effects of Inhibition of the Mitochondrial
Permeability Transition and Caspase Inhibition
on Pneumolysin-Induced Cell Death
Bongkrekate is known to inhibit the adenine nucle-
oside translocator, a protein component of the perme-
ability transition pore complex at the inner mitochon-
drial membrane. Cotreatment of SH-SY5Y cells with
bongkrekate resulted in significant protection from
FIG. 2. Pneumolysin led to strong [Ca2]i increases in neuroblastoma cells. (A) Cell culture medium was added to cells as a negative control
(a representative single-cell measurement out of 20 simultaneously recorded cells per observation field is depicted here; experiments performed
in triplicate). (B) Pneumolysin 0.5 g/ml was added to cells 2 min before start of measurement. Almost half of the cells showed a strong
elevation of [Ca2]i in the micromolar range starting at approximately 10–20 min after addition of pneumolysin. Initially, [Ca2]i concentrations
decreased but subsequent oscillations led to a persistent [Ca2]i elevation. A representative single-cell measurement out of 25 simultaneously
recorded cells per randomly chosen observation area is depicted here. Experiments were performed in quadruplicate.
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FIG. 4. Calcium influx was not mediated by voltage-sensitive Ca2 channels or ionotropic glutamate receptors. (A) The addition of CdCl2 (200
M) to block voltage-gated Ca2 channels did not affect pneumolysin-induced rises in [Ca2]i. (B) Cells were incubated with CNQX (5 M) and
CPP (10 M) to block ionotropic glutamate receptors. Basal calcium levels remained unaffected. The pneumolysin-induced increase in [Ca2]i
was not inhibited (representative measurement out of 15 simultaneously recorded cells in a randomly chosen observation area; experiments
performed in duplicate).
FIG. 3. In SH-SY5Y human neuronal cells [Ca2]i increase was due to influx of extracellular calcium and not to mobilization of intracellular
stores. (A) Stimulation with 0.5 g/ml pneumolysin (Ply) in the presence of Ca2-free bathing solution. No significant [Ca2]i changes were
observed (representative single-cell measurement out of 15 cells recorded per randomly chosen observation field; experiments performed in
triplicate). (B) Incubation of human neuronal cells with thapsigargin prior to treatment with pneumolysin. Intracellular Ca2 stores were
depleted by preincubation with 100 nM thapsigargin for 30 min, before 0.5 g/ml pneumolysin (Ply) was added to the cells. Nearly 50% of
the cells showed a strong elevation of [Ca2]i in the micromolar range starting 10–15 min after addition of pneumolysin. Again the initial
decrease was followed by persistently elevated [Ca2]i levels. A representative single-cell measurment out of 24 cells recorded is shown.
Thapsigargin alone induced a transient [Ca2]i elevation in the range of 100 nM lasting approximately 10 min. Experiments were performed
in duplicate. (C) Intracellular Ca2 stores were depleted by preincubation with 100 nM thapsigargin and 1 M FCCP for 20 and 5 min,
respectively, before 0.5 g/ml pneumolysin (Ply) was added to cells (representative measurement out of 15 simultaneously recorded cells in
a randomly chosen observation area). Nearly half of the cells recorded showed a strong elevation of [Ca2]i in the micromolar range starting
after addition of pneumolysin. Again the initial decrease was followed by persistently elevated [Ca2]i levels. Experiments were performed in
triplicate.
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pneumolysin cytotoxicity as assessed by the MTT re-
duction assay (Fig. 7) and trypan blue exclusion.
Phase-contrast microscopy of cells revealed that co-
incubation with bongkrekate also prevented morpho-
logic alterations seen after treatment with pneumoly-
sin alone.
Co-incubation of cells with the polycaspase inhibi-
tor z-VAD-fmk also exerted significant protection
against challenge with pneumolysin as determined by
the MTT reduction assay (Fig. 7). However, cells dis-
played morphologic alterations (shrinkage of cell bod-
ies and loss of neurites) similar to those seen after
exposure to pneumolysin alone.
Pneumolysin Was Present in the CSF of Animals
with Experimental Pneumococcal Meningitis
In experimental pneumococcal meningitis 24 h after
intracisternal injection of 106 CFU S. pneumoniae, CSF
concentrations of pneumolysin up to approximately
4.34 g/ml were measured by Western blotting (Fig.
8). These data demonstrate that pneumolysin is
present in the CSF at concentrations comparable to
those used in our present study.
DISCUSSION
Brain damage in bacterial meningitis appears to be
caused by the interplay of host inflammatory re-
sponses and direct toxicity of bacteria. Although the
role of the inflammatory burst triggered by bacteria in
the CNS has been extensively studied (Zysk et al.,
1996; Braun et al., 1999b; Schmidt et al., 2001; Nau &
Bru¨ck, 2002), the mechanisms by which bacteria may
directly damage neurons are poorly understood.
In this study we show that pneumolysin, a cytoplas-
mic pneumococcal protein, led to a time-dependent
toxicity to human neuronal cells. This was accompa-
nied by early cell shrinkage and the appearance of
FIG. 6. Pneumolysin-induced cell death depended on activation of
p38 MAPK. (A) MTT test of cells exposed to either medium or 0.5
g/ml pneumolysin (Ply) in the presence or absence of SB 203580
(20 M) for 12 h. There was improved survival for cells co-incu-
bated with SB 203580 and pneumolysin as compared with those
treated with pneumolysin alone. data presented as means  SD;
***P  0.001, n  8 for each condition. At 12 h after treatment with
pneumolysin protection by SB 203580 was not complete, however at
earlier time points (3, 6, 9 hours) protection was nearly 100%. (B)
Western blotting detecting phosphorylated (top) and nonphospho-
rylated (bottom) p38 MAPK at the indicated periods following
pneumolysin (0.5 g/ml) stimulation. Assessment of the nonphos-
phorylated p38 MAPK levels was performed to ensure that equal
amounts of total p38 MAPK were present at each time point. Sam-
ples of cells treated for 24 h with sodium nitroprusside (SNP) served
as positive controls. Experiments performed in quadruplicate.
FIG. 5. Chelation of intracellular calcium with BAPTA-AM pro-
tected human neuronal cells from pneumolysin-induced toxicity.
Cells were treated with either medium, or 0.5 g/ml pneumolysin
for 4 h, or 0.5 g/ml pneumolysin for 4 h after pretreatment of cells
for 30 min with 10 M BAPTA-AM (BAPTA) or BAPTA-AM alone
and assessed using the MTT test. BAPTA-AM reduced neuronal cell
death caused by pneumolysin. Data presented as means  SD).
***P  0.001. There was no statistical difference between cells
treated with BAPTA only and those treated with both BAPTA and
pneumolysin. BAPTA-AM alone was moderately toxic on SH-SY5Y
cells. The difference between cells treated with medium and those
treated with either both BAPTA and pneumolysin or BAPTA alone
was also significant (P  0.001; n  8 for each condition, experi-
ments performed in duplicate).
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nuclear alterations and DNA fragmentation in chro-
matin stains and by in situ tailing, suggesting apopto-
sis. In agreement with previous studies (Kim et al.,
1995; Kim & Ta¨uber, 1996) heat-inactivated bacteria
did not possess significant neurotoxicity on isolated
neuronal cells, whereas the proinflammatory proper-
ties, probably mediated by cell wall components, were
preserved in heat-inactivated pneumococci. Pneumo-
lysin is released mainly during autolysis of bacteria
(Rossjohn et al., 1998), and its mode of action requires
conformational integrity. Its toxicity was overlooked
when heat inactivation was applied. We next evalu-
ated whether pneumolysin is also toxic to neurons in
a tissue context. To this end hippocampal organotypic
cultures of mice were used. Challenge with low con-
centration pneumolysin resulted in cell death re-
stricted mainly to the dentate gyrus of the hippocam-
pal formation. Surrounding tissue was largely spared
from pneumolysin toxicity. Very small doses of pneu-
molysin (0.5–0.6 g/ml) were required for damage of
both isolated neuronal cells and OTCs. This is more
than one magnitude lower than concentrations (10–30
g/ml) required for similar effects on human micro-
vascular cells (Zysk et al., 2001) and argues for a par-
ticular susceptibility of neurons to pneumolysin.
Pneumolysin binds to cholesterol on membranes
where it oligomerizes into ring-shaped structures with
subsequent pore and vesicle formation within the bi-
layer (Bonev et al., 2001; Gilbert et al., 1999). We hy-
pothesized that formation of pores on the cell mem-
brane might lead to Ca2 influx with detrimental ef-
fects on cell survival. Using ratiometric calcium
measurements we showed that low concentrations of
pneumolysin led to increases in [Ca2]i in the micro-
molar range. The observed [Ca2]i increases were due
to influx of extracellular Ca2 and did not result from
mobilization of intracellular stores (Fig. 3A, 3B, 3C).
Our results strongly support the concept that Ca2
influx is essentially mediated by the pneumolysin
pore itself and not via voltage-gated Ca2 channels
(Fig. 4A, 4B). [Ca2]i following pneumolysin stimula-
tion displayed an oscillating pattern with initial re-
turns to baseline values. Furthermore, chelation of
intracellular calcium with BAPTA-AM strongly re-
duced neuronal cell death by pneumolysin. However,
viability of pneumolysin-treated cells was not com-
pletely restored by pretreatment with BAPTA-AM
probably due to the toxic effects of low intracellular
FIG. 7. Inhibition of mitochondrial permeability transition and
caspase activity rescued SH-SY5Y cells from pneumolysin-induced
toxicity. Cells were incubated with medium only or with 0.5 g/ml
pneumolysin in the presence or absence of either 20 M z-VAD-fmk
(z-VAD) or 20 M bongkrekate (BK) for 4 h. Asterisks denote
statistically significant differences between cells stimulated with
pneumolysin and cells co-incubated with pneumolysin in the pres-
ence of either z-VAD or BK Results expressed as means  SD; P 
0.001, n  8 for each condition. There was also a statistically signif-
icant difference between medium-treated cells and those treated
with pneumolysin in the presence of either z-VAD-fmk or
bongkrekate (P  0.05; experiments performed in triplicate).
FIG. 8. Presence of pneumolysin in the CSF of experimental animals. Rabbits were inoculated with 106 CFU of S. pneumoniae, and CSF was
withdrawn at 24 h. Western blotting using a dilution series of purified pneumolysin (ply standard) and a 1:200 prediluted 10-l CSF sample
is depicted here. The value obtained from densitometric assessment of concentrations was multiplied by 2000, yielding a concentration of 4.34
g/ml in CSF.
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calcium in SH-SY5Y cells (McGinnis et al., 1999). Pneu-
molysin pore assembly on cell membranes has been
suggested to be a multi-step process involving confor-
mational shifts, aggregation of liposomes, and mem-
brane destabilization (Rossjohn et al., 1998; Bonev et
al., 2001). These changes probably lead to variations in
the pore’s Ca2 conductivity. This and the action of
protective Ca2 homeostatic mechanisms (Herrington
et al., 1996), buffering and extruding Ca2 from the
cell, might account for the observed shape of Ca2
transients.
Rises in [Ca2]i, most notably through NMDA re-
ceptors, have been implicated in the pathogenesis of
disorders such as stroke, Alzheimer‘s disease, Parkin-
son‘s disease, and amyotrophic lateral sclerosis
(Doble, 1999). Ca2 influx into cells leads to activation
of several molecules including neuronal nitric oxide
synthase, CaM kinase II, and MAP kinases (Kawasaki
et al., 1997; Mason et al., 1999). We examined the
activation of p38 MAPK and demonstrated an increase
in phosphorylation as early as 30 min after stimulation
with pneumolysin. Moreover, inhibition of p38 MAPK
by its specific inhibitor SB 203580 led to a strong
improvement of cell survival. Although dual-specific-
ity kinases, such as MKK3 and MKK6, can directly
activate p38 MAPK (Harper & LoGrasso, 2001), the
links between cytoplasmic Ca2 elevations and p38
MAPK phosphorylation are not known in detail. Cal-
cineurin has been shown to induce p38 MAPK activa-
tion following Ca2 influx in myeloid cells (Lotem et
al., 1999). Yet, inhibition of calcineurin with cyclo-
sporin A had no effect on either p38 MAPK activation
or cell survival (data not shown).
Opening of the mitochondrial permeability transi-
tion (MPT) pore is critical for many types of apoptotic
and necrotic cell death and can occur through rises in
cytoplasmic calcium (Susin et al., 1998; Crompton,
1999). Bongkrekate, an inhibitor of the adenosine nu-
cleoside translocator, suppresses pneumolysin-in-
duced cell death (present study). Challenge of neurons
with either pneumolysin or pneumococcal H2O2 leads
to rises in cytoplasmic calcium and the secretion of
apoptosis-inducing factor (AIF) from mitochondria
(Braun et al., 2002). These observations demonstrate
the central role of mitochondrial damage during direct
bacterial neurotoxicity. We also found the broad-spec-
trum caspase inhibitor z-VAD-fmk to be moderately
protective against pneumolysin-induced toxicity, sug-
gesting that caspases are involved in pneumolysin-
induced cell death. This is in contrast to previous
findings (Braun et al., 2001), where direct pneumococ-
cal toxicity to rat primary neurons was caspase inde-
pendent. Possibly our use of a human neuronal cell
line instead of rat primary cells might account for
these differences.
In conclusion, stimulation of neuronal cells with
pneumolysin leads to massive Ca2 influx which is
followed by activation of p38 MAPK and probably
opening of the MPT pore with consecutive caspase
activation. Our data show that neurotoxicity of pneu-
molysin leads to apoptosis and suggest that it contrib-
utes to brain damage observed in pneumococcal men-
ingitis. Concentrations of pneumolysin up to 4.34
g/ml can be detected in the CSF of experimental
animals 24 h after induction of meningitis (Fig. 8).
Recently, Kerstan et al. (2002) found that pneumolysin
reaches concentrations of approximately 200 pg/ml in
patients with meningitis. These findings further cor-
roborate the implications of present study. Pharmaco-
logic intervention to modulate the pneumolysin-initi-
ated cell death cascade in vivo may therefore prove
beneficial in a clinical setting.
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